BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
18.40
-0.77 (-4.02%)
Nov 20, 2024, 4:00 PM EST - Market closed
BioAge Labs Employees
BioAge Labs had 56 employees as of December 31, 2023.
Employees
56
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,266,750
Market Cap
659.62M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 56 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| InnovAge Holding | 2,350 |
| agilon health | 1,117 |
| Adaptive Biotechnologies | 709 |
| Butterfly Network | 225 |
| IRADIMED CORPORATION | 148 |
| CorMedix | 83 |
| Arbutus Biopharma | 73 |
| Tectonic Therapeutic | 44 |
BIOA News
- 13 days ago - BioAge Labs Reports Third Quarter 2024 Financial Results and Provides Business Updates - GlobeNewsWire
- 7 weeks ago - BioAge Labs Announces Closing of Initial Public Offering, Full Exercise of Underwriters' Option to Purchase Additional Shares and Closing of the Concurrent Private Placement - GlobeNewsWire
- 7 weeks ago - BioAge Labs: Weighing The Risks And Rewards Of A Biotech Revival - Seeking Alpha
- 7 weeks ago - U.S. IPO Weekly Recap: 3 Sizable Deals Trade Up - Seeking Alpha
- 7 weeks ago - BioAge valued at $758 mln in debut as investors bet on weight-loss drug frenzy - Reuters
- 7 weeks ago - BioAge Labs IPO: Stock price will be closely watched today as the obesity drug developer debuts on the Nasdaq - Fast Company
- 7 weeks ago - Natural-gas producer BKV and drug-developer BioAge queue up IPOs - Market Watch
- 2 months ago - Weight-loss drug developer BioAge raises $198 mln in U.S. IPO - Reuters